Zydus Wellness Q4 results: Net profit up 9.02%, final dividend announced

The revenue from operations rose 11.44 per cent to Rs 712.98 crore in the quarter

BS Web Team New Delhi
zydus wellness q4

Listen to This Article

Zydus Wellness Ltd reported a 9.02 per cent rise in its net profit in the quarter that ended on March 31, 2023 to Rs 145.33 crore from Rs 133.30 crore in the same quarter in 2022, the company said in a BSE filing. The revenue from operations rose 11.44 per cent to Rs 712.98 crore in the quarter from Rs 639.78 crore last year.
In 2022-23, the company's net profit rose 0.48 per cent to Rs 310.37 crore as compared to Rs 308.87 crore in the previous year.

The pharma company also recommended a final dividend of Rs 5 per share, which will be given on approval of the members at the company's Annual General Meeting scheduled to be held on August 3, 2023.
For the first time, Glucon-D crossed 60 per cent market share during the financial year, the company said. "The brand maintained its number one position with a market share of 60.1 per cent as per MAT March 2023 report of Nielsen, registering an increase of 159 basis points over the same period last year," it said in a release on Wednesday.

Sugar Free and Nycil also continue to maintain their leadership in the Indian market, the company said.  
The company also reported 11.8 per cent growth in consolidated net sales which stood at Rs 709.9 crores in the quarter.

Also Read

Decent upside in select sugar stocks as business prospects turn sweeter

Sugar industry MSME margins hit by flat product prices: CRISIL SME TRACKER

Renuka, EID Parry: Sugar stocks to sweeten as global prices hit 11 yr-high

From Adani Wilmar to Havells India: Q4 results to watch out for today

Export quota hike may trigger up to 33% rally in these 3 sugar stocks

Triveni Turbine net profit grows 68% to Rs 55.6 cr in March quarter

Oberoi Realty Q4 results: Consolidated net profit rises 106% to Rs 480 cr

NASDAQ-listed firm MakeMyTrip posts $5.4 million profit for Jan-Mar quarter

Jindal Steel and Power Q4 results: PAT falls 69.4% to Rs 466 crore

Granules profit up 7.8% to Rs 120 crore boosted by drug ingredient business

First Published: May 17 2023 | 12:55 PM IST

Explore News